ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för avanafil. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

13 träffar

Bibliografisk träff 2012-07-12

A phase II, single-blind, randomized, crossover evaluation of the safety and efficacy of avanafil using visual sexual stimulation in patients with mild to moderate erectile dysfunction.

Hellstrom WJ, Freier MT, Serefoglu EC, Lewis RW, DiDonato K, Peterson CA.

BJU Int · clinical trial, phase ii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1111/j.1464-410x.2012.11267.x

Bibliografisk träff 2012-07-03

Selectivity of avanafil, a PDE5 inhibitor for the treatment of erectile dysfunction: implications for clinical safety and improved tolerability.

Wang R, Burnett AL, Heller WH, Omori K, Kotera J, Kikkawa K, Yee S, Day WW, DiDonato K, Peterson CA.

J Sex Med · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1111/j.1743-6109.2012.02822.x

Bibliografisk träff 2012-06-15

Avanafil, a potent and highly selective phosphodiesterase-5 inhibitor for erectile dysfunction.

Kotera J, Mochida H, Inoue H, Noto T, Fujishige K, Sasaki T, Kobayashi T, Kojima K, Yee S, Yamada Y, Kikkawa K, Omori K.

J Urol · comparative study; journal article · DOI 10.1016/j.juro.2012.03.115

Bibliografisk träff 2012-03-27

Efficacy and safety of avanafil for treating erectile dysfunction: results of a multicentre, randomized, double-blind, placebo-controlled trial.

Zhao C, Kim SW, Yang DY, Kim JJ, Park NC, Lee SW, Paick JS, Ahn TY, Moon KH, Chung WS, Min KS, Suh JK, Hyun JS, Park K, Park JK.

BJU Int · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1111/j.1464-410x.2012.11095.x

Bibliografisk träff 2012-01-16

A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction.

Goldstein I, McCullough AR, Jones LA, Hellstrom WJ, Bowden CH, Didonato K, Trask B, Day WW.

J Sex Med · comparative study; multicenter study; randomized controlled trial; journal article · DOI 10.1111/j.1743-6109.2011.02629.x

Bibliografisk träff 2012-01-01

Avanafil for the treatment of erectile dysfunction.

Segal R, Burnett AL.

Drugs Today (Barc) · review; journal article · DOI 10.1358/dot.2012.48.1.1722068

Bibliografisk träff 2011-10-18

Future prospects in the treatment of erectile dysfunction: focus on avanafil.

Alwaal A, Al-Mannie R, Carrier S.

Drug Des Devel Ther · review-article; review; journal article · DOI 10.2147/dddt.s15852

Bibliografisk träff 2011-09-09

Novel phosphodiesterase type 5 modulators: a patent survey (2008 - 2010).

Bell AS, Palmer MJ.

Expert Opin Ther Pat · review; journal article · DOI 10.1517/13543776.2011.614435

Bibliografisk träff 2011-08-01

Phosphodiesterase (PDE) inhibitors in the treatment of lower urinary tract dysfunction.

Uckert S, Oelke M.

Br J Clin Pharmacol · review-article; review; journal article · DOI 10.1111/j.1365-2125.2010.03828.x

Bibliografisk träff 2010-10-13

Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction.

Limin M, Johnsen N, Hellstrom WJ.

Expert Opin Investig Drugs · review; journal article · DOI 10.1517/13543784.2010.518955

Bibliografisk träff 2010-06-01

Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: a single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers.

Jung J, Choi S, Cho SH, Ghim JL, Hwang A, Kim U, Kim BS, Koguchi A, Miyoshi S, Okabe H, Bae KS, Lim HS.

Clin Ther · research support, non-u.s. gov't; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1016/j.clinthera.2010.06.011

Bibliografisk träff 2008-06-01

Novel phosphodiesterase-5 (PDE5) inhibitors in the alleviation of erectile dysfunction due to diabetes and ageing-induced oxidative stress.

Gur S, Sikka SC, Hellstrom WJ.

Expert Opin Investig Drugs · review; journal article · DOI 10.1517/13543784.17.6.855

Bibliografisk träff 2008-01-01

Looking to the future for erectile dysfunction therapies.

Hatzimouratidis K, Hatzichristou DG.

Drugs · review; journal article · DOI 10.2165/00003495-200868020-00006